The core lesson is that the American research university is “the indispensable foundation for innovation,” they conclude. The ...
Since the last survey, CFOs added 1.1 percentage points to their firm’s unit cost and price growth projections for 2026.
A simple shift in the timing of companies’ earnings announcements can improve firms’ investment decisions and make their stocks easier to trade. In “Dancing to the Fed's Tune: Earnings Announcement ...
Marketers are increasingly pessimistic about the economy, with sentiment reaching its lowest level since the pandemic in 2020. In response—and facing organizational pressures for returns—marketing ...
The outlook for the U.S. economy improved among financial decision-makers in the first quarter of 2026, according to The CFO Survey, a collaboration of Duke University’s Fuqua School of Business and ...
CFOs remain concerned about tariffs and anticipate price increases of more than 3 percent in 2026, while expecting moderate growth in employment and overall economic activity. Widespread increases in ...
When you open your favorite music streaming app and see a playlist that feels made for you, or you scroll through an online store that seems to ‘know’ what you like, you’re seeing the power of ...
A new AI tool developed at Duke University’s Fuqua School of Business may change how the world identifies promising research, before it ever earns a citation or patent. By predicting value before ...
People using AI may face a social stigma in the workplace. Artificial intelligence – often touted for improving performance — could also damage people’s professional reputation, Fuqua researchers ...
Small businesses selling on ecommerce marketplaces often complain about the unfairness of the platforms prioritizing their own products — like Amazon Basics — in the prominent “sponsored ad” slots in ...
An “unprecedented” federal program to support troops’ medical needs in World War II led to the emergence of the modern US biomedical system, spurring decades of expansion in medical research and drug ...